She completed her PhD and postdoctoral training in Neuroscience at Cambridge University and her undergraduate degree at Oxford University. Following her academic work, she worked in EU Pharma & Biotech equity research at Goldman Sachs. She later co-founded and was the CEO of Sixfold Bioscience prior to joining Lilly.